Preliminary Study 2 to Test the Effects of Ambulatory Voice Biofeedback

NACompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

June 1, 2018

Primary Completion Date

January 25, 2024

Study Completion Date

February 5, 2024

Conditions
Vocal Fold NodulesMuscle Tension Dysphonia
Interventions
BEHAVIORAL

Ambulatory voice biofeedback

Patients will be provided cues regarding their vocal behavior in daily life. Specifically, the patient will receive 100% feedback = a vibrotactile cue on a smartwatch every time the patient voices incorrectly. The specific objective voice measure for biofeedback will depend upon which measure is most strongly associated with improvements during voice therapy.

Trial Locations (1)

02114

Massachusetts General Hospital - Center for Laryngeal Surgery and Voice Rehabilitation, Boston

All Listed Sponsors
collaborator

National Institute on Deafness and Other Communication Disorders (NIDCD)

NIH

lead

Massachusetts General Hospital

OTHER

NCT03416868 - Preliminary Study 2 to Test the Effects of Ambulatory Voice Biofeedback | Biotech Hunter | Biotech Hunter